Close Menu

Bruker

ArcDia's agreement with Bruker subsidiary Hain Lifescience is exclusive in Germany, Austria, Switzerland, Belgium, the Netherlands, and Luxembourg.

The FluoroType SARS-CoV-2 plus real-time PCR test can distinguish SARS-CoV-2 from other coronaviruses that can cause the common cold.

The deal took effect immediately and shipments have to Spain, France, Germany, and the UK have begun.

News items for the in vitro diagnostics industry for the week of Feb. 17, 2020. 

The instrument's ability to run in negative-ion mode allows it to move beyond its traditional focus on proteins and into the analysis of other analyte classes.

Get the latest news from Bruker, Veracyte, Natera, VolitionRx, Celcuity, Genome Diagnostics, Verogen, iGene Labs, and Danaher for the week of 5/10/19.

Get the latest news from Danaher, HTG Molecular, Bruker, Myriad Genetics, Beckton Dickinson, RenalytixAI, Caris Life Sciences, and Oxford BioDynamics for the week of 5/3/19.

Based on PCR technology acquired from Hain Diagnostics, the test and platform enable rapid detection of TB, as well as assessment of antibiotic resistance.

Lab director Glenn George discusses trends within clinical microbiology that could set it apart from other portions of the clinical laboratory.

Pages